BREAKING
Kilroy Realty Reports Q1 2026 Loss: -$0.16/Share vs $0.35 Expected 12 hours ago Ecolab Q1 2026: Revenue Hits $4.07B, Up 10% Year-Over-Year 12 hours ago Nucor Jumps 5.5% After UBS Downgrades to Neutral 13 hours ago LGI Homes Edges Past Q1 2026 Estimates, Posts $0.24 EPS, Revenue Down 9% 14 hours ago Molina Healthcare Jumps 5.7% After Wells Fargo Maintains Equal-Weight 14 hours ago COPT Defense Properties Crushes Q1 2026 Profit Estimates 14 hours ago Cincinnati Financial Delivers 12% Revenue Growth in Q1 2026 15 hours ago Armstrong World Industries Falls Short of Q1 2026 Profit Forecast at $1.69 EPS 15 hours ago Franklin Resources Releases Q2 2026 Financial Results 15 hours ago JetBlue Airways Reports 20.8% Wider Q1 2026 Loss at -$0.87/Share 15 hours ago Kilroy Realty Reports Q1 2026 Loss: -$0.16/Share vs $0.35 Expected 12 hours ago Ecolab Q1 2026: Revenue Hits $4.07B, Up 10% Year-Over-Year 12 hours ago Nucor Jumps 5.5% After UBS Downgrades to Neutral 13 hours ago LGI Homes Edges Past Q1 2026 Estimates, Posts $0.24 EPS, Revenue Down 9% 14 hours ago Molina Healthcare Jumps 5.7% After Wells Fargo Maintains Equal-Weight 14 hours ago COPT Defense Properties Crushes Q1 2026 Profit Estimates 14 hours ago Cincinnati Financial Delivers 12% Revenue Growth in Q1 2026 15 hours ago Armstrong World Industries Falls Short of Q1 2026 Profit Forecast at $1.69 EPS 15 hours ago Franklin Resources Releases Q2 2026 Financial Results 15 hours ago JetBlue Airways Reports 20.8% Wider Q1 2026 Loss at -$0.87/Share 15 hours ago
ADVERTISEMENT
ABT

Abbott Laboratories

$ABT NYSE Feb 20, 2026 All Day Q2 2026

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

ABT Coverage

Event Abbott Laboratories (ABT) Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform Apr 28, 2026 Event Abbott Laboratories (ABT) Sec Form 8K Apr 27, 2026 Event Abbott Laboratories (ABT) Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026 Apr 25, 2026 Transcript Abbott Laboratories (ABT) Q1 2026 Earnings Call Transcript Apr 16, 2026 News Abbott Laboratories Shares Dropping 5.6% Apr 16, 2026 News Abbott (ABT) Q1 FY26 earnings match estimates; sales beat Apr 16, 2026 News Abbott Heads Into Earnings With Diagnostics in Focus Apr 14, 2026 Transcript Abbott Laboratories (ABT) Q4 2025 Earnings Call Transcript Feb 8, 2026